Smarter in Minutes #6: Long COVID***Post-Survey & Application for CME Credit***

In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 75% on this post-survey, as well as complete the evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements.

There is no fee to participate in this activity.

2.Management goals for Long COVID includes:(Required.)

Cure myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Workup and testing delayed when there are signs and symptoms of urgent or potentially life-threatening clinical conditions

Identify effective treatments for dysautonomia

Optimize function and quality of life

3.Which of the following are considered “Long COVID” patients (Required.)

Patients with COVID symptoms lasting for 2 weeks and then dissipate

Recovered COVID patients with no symptoms at first but who then start having symptoms months or weeks later

Patients with recurrent COVID infection but no symptoms

4.Some Long COVID symptoms aggregate into which of the following medical syndromes: (Required.)

Cognitive dysfunction

Osteoarthritis

Pollen allergies

Urinary tract infections

5.A 28-year-old female dancer sees her PCP with complaints of brain fog, racing heart, profound fatigue, and dizziness. She maintains a rigorous training schedule of 12–15-hour days and admits to significant “stress” in her professional and personal life. She was not vaccinated for COVID or influenza and had a severe “cold” several months ago from which she recovered. Which of the following diagnoses should be considered for workup given her history? (Required.)

6.Emerging evidence from a VA-Cohort study with nearly 282,000 people with SARS-CoV-2 infection who had at least one risk factor for progression to severe disease found treatment with ____________ within 5 days of symptoms was associated with reduced risk of post-COVID conditions, regardless of vaccination status and history of prior infection?(Required.)

Molnupiravir

Paxlovid

Remdesivir

Sotrovimab

EVALUATION FORM

8.*Please rate the following:

Yes

No

Did the activity address strategies for overcoming barriers to optimal patient care?

Yes

No

Was the content presented evidence-based and clinically relevant?

Yes

No

Was the material presented in an objective manner and free from commercial interest?*

Yes

No

If you answered "no" to any of the above, please comment

*(Commercial bias is defined as promoting a specific proprietary business interest of a commercial entity, and/or not including a balanced view of therapeutic options)

9.As a result of what I learned, I intend to make changes in my practice:

Extremely likely

Somewhat likely

Not at all likely

10.What change(s) will you incorporate into your practice as a result of what you have learned in this activity?

11.I certify that I have participated in the continuing education activity entitled, "SiM #6 Long COVID" and claim 0.5 AMA PRA Category 1 Credit^TM.

Yes

No

12.If you are claiming credit, please provide your contact information so we can send your certificate. Certificates will be provided within 4-6 weeks.

Please note that we will not forward or sell your contact information.

First Name

Last Name

Degree/Credentials

City

State/Province

ZIP/Postal Code

Country

Email Address (required to receive credit)

Thank you for participating in our activity and completing the necessary paperwork. Please allow 4-6 weeks to receive your certificate. For information about the certification of this program, please contact National Jewish Health at proed@njhealth.org.